Publications by authors named "Marc Boogaerts"

Claim this Profile
L
Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial.
Michel Delforge, Timothy Devos, Jacob Rowe, Ignacio Español, Simon T Durrant, Marc Boogaerts

Leuk Lymphoma· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry.
Roel J W van Kampen, Carmen Canals, Harry C Schouten, Arnon Nagler, Kirsty J Thomson, Marc A Boogaerts

J Clin Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia.
Ziyi Lim, Ronald Brand, Rodrigo Martino, Anja van Biezen, Jürgen Finke, Marc Boogaerts

J Clin Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia.
Ann Janssens, Marc Boogaerts, Gregor Verhoef

Drug Des Devel Ther· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study.
Lieven Herbots, Jan D'hooge, Elif Eroglu, Daisy Thijs, Javier Ganame, Marc Boogaerts

Eur Heart J· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of activated lymphocytes in patients with myelodysplastic syndromes: a single centre study of 131 patients.
Stef Meers, Peter Vandenberghe, Marc Boogaerts, Gregor Verhoef, Michel Delforge

Leuk Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
Nigel Russell, Rolf Mesters, Joerg Schubert, Marc Boogaerts, Hans E Johnsen

Haematologica· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Anna Sureda, Stephen Robinson, Carmen Canals, Angelo M Carella, Marc A Boogaerts

J Clin Oncol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immature and mature monocyte-derived dendritic cells in myelodysplastic syndromes of subtypes refractory anemia or refractory anemia with ringed sideroblasts display an altered cytokine profile.
Ling Ma, Jan Ceuppens, Ahmad Kasran, Michel Delforge, Marc Boogaerts

Leuk Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Vascular access in hemodialysis].
Marc Boogaerts, Magalie Marjot, Fabienne Sainte-Croix, Marie-France Gadiou, Catherine Guillet

Soins· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of treatment with epoetin Beta on thromboembolic events in anemic patients with cancer: a metaanalysis.
Bertrand Coiffier, Marc Boogaerts, Matti Aapro, Colin Hayward, Hans-Ulrich Burger

Support Cancer Ther· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.
Rodrigo Martino, Simona Iacobelli, Ronald Brand, Thekla Jansen, Anja van Biezen, Marc Boogaerts

Blood· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant.
Els Lierman, Cedric Folens, Elizabeth H Stover, Nicole Mentens, Helen Van Miegroet, Marc Boogaerts

Blood· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow cell transfer in acute myocardial infarction.
Stefan Janssens, Koen Theunissen, Marc Boogaerts, Frans Van de Werf

Nat Clin Pract Cardiovasc Med· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
Stefan Janssens, Christophe Dubois, Jan Bogaert, Koen Theunissen, Christophe Deroose, Marc Boogaerts

Lancet· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
Johan Maertens, Koen Theunissen, Gregor Verhoef, Johnny Verschakelen, Katrien Lagrou, Marc Boogaerts

Clin Infect Dis· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia models.
Marc Boogaerts, Moshe Mittelman, Peter Vaupel

Oncology· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation.
Simone Cesaro, Rosi Oneto, Chiara Messina, Brenda E Gibson, Agnes Buzyn, Marc Boogaerts

Br J Haematol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The place for itraconazole in treatment.
Johan Maertens, Marc Boogaerts

J Antimicrob Chemother· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unrecognized or potential risk factors for childhood cancer.
Nicolas A Van Larebeke, Linda S Birnbaum, Marc A Boogaerts, Marc Bracke, Devra Lee Davis

Int J Occup Environ Health· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.
Martin Dreyling, Georg Lenz, Eva Hoster, Achiel Van Hoof, Christian Gisselbrecht, Marc A Boogaerts

Blood· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic index for adult patients with acute myeloid leukemia in first relapse.
Dimitri A Breems, Wim L J Van Putten, Peter C Huijgens, Gert J Ossenkoppele, Gregor E G Verhoef, Marc A Boogaerts

J Clin Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial.
Dimitri A Breems, Marc A Boogaerts, Adriaan W Dekker, Wim L J Van Putten, Pieter Sonneveld

Br J Haematol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies.
Georgine E de Greef, Wim L J van Putten, Marc Boogaerts, Peter C Huijgens, Leo F Verdonck

Br J Haematol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
Johan Maertens, Issam Raad, George Petrikkos, Marc Boogaerts, Dominik Selleslag

Clin Infect Dis· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis